The ₹135.73 crore Hy-Tech Engineers initial public offering (IPO) entered its final day of public subscription today, August 27, 2026, with a price band of ₹50 to ₹53 per share. As of 10:09 A.M on the fourth day of bidding, the issue had been subscribed 58.09 times.
The basis of allotment is expected to be finalised on 28 August 2026, while the shares are tentatively scheduled to be listed on the NSE and BSE on 1 September 2026.
The expected IPO schedule is as follows:
|
Event |
Date |
|
Subscription Opening Date |
24 August 2026 |
|
Subscription Closing Date |
27 August 2026 |
|
Basis of Allotment Date |
28 August 2026 |
|
Refund Initiation Date |
31 August 2026 |
|
Credit of Shares |
31 August 2026 |
|
Listing on BSE and NSE |
1 September 2026 |
Note: The allotment and listing dates are tentative and may be revised.
Explore other Upcoming IPOs on BSE and NSE.
[August 27, 2026, 10:09 A.M.]
|
Category |
Subscription (x) |
|
Qualified Institutional Buyers (QIBs) |
0.86x |
|
Non-Institutional Investors (NIIs) |
103.21x |
|
Retail Individual Investors (RIIs) |
69.86x |
|
Total |
58.09x |
The company intends to utilise the net proceeds from the fresh issue towards:
Established in 1982, Hytech Engineers Limited is a precision engineering company engaged in manufacturing hydraulic fittings and flow control components for industrial applications. Its product portfolio comprises more than 11,000 standard and customised products used across sectors including construction equipment, automotive, agriculture, railways, defence, and hydraulic machinery.
The company primarily serves OEMs and industrial clients through a B2B business model, supported by long-standing customer relationships and a wide distribution network across domestic and international markets.
|
Particulars |
FY26 (in ₹ crore) |
FY25 (in ₹ crore) |
FY24 (in ₹ crore) |
|
Revenue from operations |
189.40 |
161.38 |
137.71 |
|
EBITDA |
41.69 |
35.79 |
22.55 |
|
Profit After Tax (PAT) |
22.59 |
19.62 |
11.60 |
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here.